Pharmaceuticals, Biotechnology and Life Sciences

Dong-A ST is a pharmaceutical company manufacturing prescription, over-the-counter medication, and test kits for various diseases and infections; and importing medical devices.

Bukwang Pharmaceutical is a South Korean company researching, manufacturing, and distributing its own or its subsidiaries' prescription and over-the-counter (OTC) drugs as well as licensed drugs from worldwide partners.

ChongKunDang is a South Korean pharmaceutical company manufacturing and distributing prescription and over-the-counter medication, health supplements, and consumer health and household products such as hair color and pest control products.

Yungjin Pharm is a South Korean pharmaceutical company. 

The main shareholder of Yungjin Pharm is KT&G, a company manufacturing tobacco, ginseng, and pharmaceutical products, with 52.45% of shares.

Kolmar Korea is a company researching, designing, producing and shipping cosmetics, pharmaceutical drugs, and healthy food products for business customers.

Hanall Biopharma is a South Korean biopharmaceutical company specialised in autoimmune, immuno-oncology, and IV nutrition pharmaceutical products.

Daewoong Pharmaceutical is a company manufacturing and distributing pharmaceutical products.

The company operates plants in South Korea (5), Indonesia (1), and China (2); and has branches in the US, Vietnam, India, Japan, and other Asian countries.

GC Pharma (formerly Green Cross Corporation) is a company manufacturing and distributing pharmaceutical products. The company was the first to develop a vaccine against hemorrhagic fever with renal syndrome (Hantavax) in 1988. The company has several vaccines in its pipelines, constantly developing new or improved vaccines for various illnesses such as varicella, tuberculosis, and anthrax.

Yuhan is a pharmaceutical company developing, manufacturing, and distributing pharmaceutical products domestically and abroad. 

Hanmi Pharmaceutical researches, develops, licenses, and manufactures pharmaceutical products for South Korea and overseas. The company's main outpatient products are Amosartan (hypertension-hyperlipidemia), Rosuzet (hyperlipidemia), Pal Pal (hypertension), and Esomezol (GERB).

The company has numerous products in its research and development pipeline, targeting chronic conditions such as obesity and diabetes, oncology, and rare diseases.